Skip links

Plutonet is a medical biotechnology company focussing on cell and gene-based immunotherapy, located within the Multimedia Super Corridor (MSC) at Bio-X Centre, Cyberjaya, a high-tech science and research-based development centre.

We operate from Malaysia's first Biosafety Level 2 (BSL-2) cGMP facility, in accordance to PIC/S standards by the National Pharmaceutical Regulatory Agency (NPRA), a division of Ministry of Health, Malaysia.

Our team is dedicated to the development, production, and commercialisation of cell and gene-based immuno-therapeutic products, with a primary focus on CAR T-cell therapy for the treatment of blood cancers and tumours.

Advancing Medicine through Cell and Genetic Therapies for Cancer

Plutonet is committed to developing a diverse range of treatments using cutting-edge technologies. Our focal point is on advancing these technologies to potentially address various types of blood cancers and solid tumours. Our pineline research includes the use of the following cell types:
  • CAR T-Cells
  • Cytokine-induced Killer Cells
  • Natural Killer Cells
  • Gamma Delta T Cells